dexmedetomidine
Drug ingredientActive ShortageThis drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.
Where It Comes From
3 FDA-registered drug labelers
Why It Matters
Appears in 1 drug and cosmetic product listings (FDA).
- •Igalmi
Dexmedetomidine Hydrochloride Injection
04/10/2020Available
Dexmedetomidine Hydrochloride Injection
04/10/2020Unavailable
Dexmedetomidine Hydrochloride Injection
04/10/2021Available
Dexmedetomidine Hydrochloride Injection
04/21/2026Dexmedetomidine Hydrochloride Injection
04/10/2020Limited Availability
Vendor Pricing
Prices reflect listed pack sizes. Small research packs run far above bulk rates.
6 more vendors
| Vendor | Country Supplier country. Where available, shows shipping origin. When the supplier ships from a different country than where they are registered, both are shown. Most suppliers show registration country only. | $/g | Pack | Purity |
|---|---|---|---|---|
| AstaTech, Inc | United States | $75.60 | 5 g | 97% |
| TargetMol Chemicals | China → United States | $2290.00 | 200 mg | 99.88% |
| TargetMol Chemicals US | United States | $2970.00 | 100 mg | 99.88% |
| MedChemExpress MCE | Sweden | $4755.30 | 100 mg | 99.99% |
| TargetMol Chemicals EU | Austria | $5080.00 | 25 mg | 99.88% |
| Apexbio Technology LLC | United States | $8300.00 | 50 mg | 99.76% |
Chemical Identity
Data Sources
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/dexmedetomidine/cids/JSON
Archive: data/sources/pubchem_name/dexmedetomidine.json
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json